COVID-19 vaccines – VRBPAC makes recommendations for new monovalent vaccine composition for 2025 – 2026
May 22, 2025 - The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted for the 2025 – 2026 formula of COVID-19 vaccines in the U.S to include a vaccine composition of a monovalent JN.1-lineage.
Top